KalVista Pharmaceuticals (KALV) EBIT Growth (3y) (2019 - 2025)
KalVista Pharmaceuticals (KALV) EBIT Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.96% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 38.78% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 69.02% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | KalVista Pharmaceuticals | 1.36 Bn | 1.36 Bn | 49.41 Mn | -30.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -30.89% |
| Apr 30, 2025 | -27.09% |
| Oct 31, 2024 | -24.74% |
| Jul 31, 2024 | -31.34% |
| Apr 30, 2024 | -39.00% |
| Jan 31, 2024 | -37.84% |
| Oct 31, 2023 | -32.52% |
| Jul 31, 2023 | -26.29% |
| Apr 30, 2023 | -52.44% |
| Jan 31, 2023 | -28.42% |
| Oct 31, 2022 | -40.72% |
| Jul 31, 2022 | -40.13% |
| Apr 30, 2022 | -33.53% |
| Jan 31, 2022 | -58.83% |
| Oct 31, 2021 | -68.97% |
| Jul 31, 2021 | -40.68% |
| Apr 30, 2021 | -82.48% |
| Jan 31, 2021 | -42.81% |
| Oct 31, 2020 | -29.12% |
| Jul 31, 2020 | -38.36% |